Ana I. Rojo and Robert et al. suggested that Nrf2 is a critical element in survival and death decisions when neurons are exposed to an oxidant environment and proposed the use of Nrf2 agonists as immune therapies for cancer and infection [60, 61]. Here, NFE2L2 is linked to infection.